Anthera Pharmaceuticals Inc

NEW
OTCPK:ANTH (USA)  
$ 0.00010 (0%) 10:08 PM EST
At Loss
Market Cap:
$ 3.00K
Enterprise V:
$ 3.00K
Volume:
0
Avg Vol (2M):
3.63K
Trade In:
Volume:
0
At Loss
Avg Vol (2M):
3.63K

Business Description

Anthera Pharmaceuticals Inc
NAICS : 325412 SIC : 2834
ISIN : US03674U3005
Description
Anthera Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases. The company currently has one Phase 3-ready clinical program and two Phase 2 clinical programs. It was established in 2004.

Financial Strength

Name Current Vs Industry Vs History

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI
0.59
9-Day RSI
6.4
14-Day RSI
15.98

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History

GF Value Rank

Name Current Vs Industry Vs History
FCF Yield %
-1065066.67

Financials

ANTH's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:ANTH

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Anthera Pharmaceuticals Inc Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -1.7
Beta -128.5929
3-Year Sharpe Ratio 0.54
3-Year Sortino Ratio 4.73
Volatility % 912.59
14-Day RSI 15.98
14-Day ATR ($) 0.000008
20-Day SMA ($) 0.0001
12-1 Month Momentum % -
52-Week Range ($) 0.00001 - 0.001
Shares Outstanding (Mil) 26.18

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Anthera Pharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

Anthera Pharmaceuticals Inc Stock Events

Financials Calendars
Event Date Price ($)
0.125:1 Stock Split 2017-05-01 2.64 (-8.33%)
0.125:1 Stock Split 2013-07-15 32.64 (+4.08%)
Show
Entries

Anthera Pharmaceuticals Inc Frequently Asked Questions

What is Anthera Pharmaceuticals Inc(ANTH)'s stock price today?
The current price of ANTH is $0.00. The 52 week high of ANTH is $0.00 and 52 week low is $0.00.
When is next earnings date of Anthera Pharmaceuticals Inc(ANTH)?
The next earnings date of Anthera Pharmaceuticals Inc(ANTH) is .
Does Anthera Pharmaceuticals Inc(ANTH) pay dividends? If so, how much?
Anthera Pharmaceuticals Inc(ANTH) does not pay dividend.

Guru Commentaries on OTCPK:ANTH

No fund manager commentary yet.

Press Release

Subject Date
No Press Release

Articles on Anthera Pharmaceuticals Inc

No articles.

Headlines

See More
  • 1
No news.
  • 1